株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

米国における固形腫瘍検査市場:2018年〜2022年

Solid Tumor Testing Market in the US 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 353218
出版日 ページ情報 英文 109 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.09円で換算しております。
Back to Top
米国における固形腫瘍検査市場:2018年〜2022年 Solid Tumor Testing Market in the US 2018-2022
出版日: 2018年05月03日 ページ情報: 英文 109 Pages
概要

固形腫瘍検査について

固形腫瘍検査は、癌の早期発見に役立つ医療処置です。体全体に癌性細胞が広がらないようにし、効果的な治療を可能にするために行われます。

Technavioのアナリストは、米国の固形腫瘍検査市場が2018年から2022年の間に10.72%のCAGRで成長すると予測しています。

当レポートでは、米国の固形腫瘍検査市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模(2017年)
  • 市場規模および予測(2017-2022年)

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第7章 市場セグメンテーション:技術別

  • セグメンテーション:技術別(2017-2022年)
  • 比較:技術別
  • 従来の検査 - 市場規模と予測
  • 非従来の検査 - 市場規模と予測
  • 市場機会:技術別

第8章 顧客情勢

第9章 分割:エンドユーザ別

  • セグメンテーション:エンドユーザー別(2017-2022年)
  • 比較:エンドユーザー別
  • 病院 - 市場規模と予測
  • 診断研究所 - 市場規模と予測
  • 学術機関および研究機関 - 市場規模と予測
  • 市場機会:エンドユーザー別

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第12章 市場動向

  • 癌診断におけるNGSの採用
  • 伝統的な生検に対する液体生検の優先
  • 癌研究への投資の増加

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Danaher
  • F. Hoffmann-La Roche
  • Illumina
  • Thermo Fisher Scientific

第15章 付録

  • 略語のリスト
図表
  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Solid tumor testing market in the US- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 08: Solid tumor testing market in the US - Year-over-year growth 2018-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017 and 2022
  • Exhibit 17: Solid tumor testing market in the US by technology - Market share 2017-2022 (%)
  • Exhibit 18: Comparison by technology
  • Exhibit 19: Conventional tests for solid tumors associated with various types of cancer
  • Exhibit 20: Conventional testing - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 21: Conventional testing - Year over year growth 2018-2022 (%)
  • Exhibit 22: Non-conventional testing - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 23: Non-conventional testing - Year over year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by technology
  • Exhibit 25: Customer landscape
  • Exhibit 26: Solid tumor testing market in the US by end-user - Market share 2017-2022 (%)
  • Exhibit 27: Comparison by end-user
  • Exhibit 28: Hospitals - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 29: Hospitals - Year over year growth 2018-2022 (%)
  • Exhibit 30: Diagnostic laboratories - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 31: Diagnostic laboratories - Year over year growth 2018-2022 (%)
  • Exhibit 32: R&D funding for cancer 2013-2016 ($ millions)
  • Exhibit 33: Academic and research institutes- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 34: Academic and research institutes - Year over year growth 2018-2022 (%)
  • Exhibit 35: Market opportunity by end-user
  • Exhibit 36: Cost of sequencing per genome 2001-2015 ($)
  • Exhibit 37: Vendor landscape
  • Exhibit 38: Landscape disruption
  • Exhibit 39: Vendors covered
  • Exhibit 40: Vendor classification
  • Exhibit 41: Market positioning of vendors
  • Exhibit 42: Agilent Technologies overview
  • Exhibit 43: Agilent Technologies- Business segments
  • Exhibit 44: Agilent Technologies - Organizational developments
  • Exhibit 45: Agilent Technologies - Geographic focus
  • Exhibit 46: Agilent Technologies - Segment focus
  • Exhibit 47: Agilent Technologies - Key offerings
  • Exhibit 48: Becton, Dickinson and Company overview
  • Exhibit 49: Becton, Dickinson and Company - Business segments
  • Exhibit 50: Becton, Dickinson and Company - Organizational developments
  • Exhibit 51: Becton, Dickinson and Company - Geographic focus
  • Exhibit 52: Becton, Dickinson and Company - Segment focus
  • Exhibit 53: Becton, Dickinson and Company - Key offerings
  • Exhibit 54: Danaher overview
  • Exhibit 55: Danaher - Business segments
  • Exhibit 56: Danaher - Organizational developments
  • Exhibit 57: Danaher- Geographic focus
  • Exhibit 58: Danaher- Segment focus
  • Exhibit 59: Danaher - Key offerings
  • Exhibit 60: F. Hoffmann-La Roche overview
  • Exhibit 61: F. Hoffmann-La Roche- Business segments
  • Exhibit 62: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 63: F. Hoffmann-La Roche- Geographic focus
  • Exhibit 64: F. Hoffmann-La Roche- Segment focus
  • Exhibit 65: F. Hoffmann-La Roche - Key offerings
  • Exhibit 66: Illumina overview
  • Exhibit 67: Illumina - Business segments
  • Exhibit 68: Illumina - Organizational developments
  • Exhibit 69: Illumina - Geographic focus
  • Exhibit 70: Illumina - Segment focus
  • Exhibit 71: Illumina - Key offerings
  • Exhibit 72: Thermo Fisher Scientific overview
  • Exhibit 73: Thermo Fisher Scientific- Business segments
  • Exhibit 74: Thermo Fisher Scientific- Organizational developments
  • Exhibit 75: Thermo Fisher Scientific- Geographic focus
  • Exhibit 76: Thermo Fisher Scientific- Segment focus
  • Exhibit 77: Thermo Fisher Scientific- Key offerings
目次
Product Code: IRTNTR21773

About Solid Tumor Testing

Solid tumor testing is a medical procedure that helps in the early detection of cancer. It is done to avoid the spread of cancerous cells throughout the body and allow for effective treatment.

Technavio's analysts forecast the solid tumor testing market in the US to grow at a CAGR of 10.72% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the solid tumor testing market in the US for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

Technavio's report, Solid Tumor Testing Market in the US 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agilent Technologies
  • Becton, Dickinson and Company
  • Danaher
  • F. Hoffmann-La Roche
  • Illumina
  • Thermo Fisher Scientific

Market driver

  • Growing prevalence of cancer
  • For a full, detailed list, view our report

Market challenge

  • High cost of sequencing
  • For a full, detailed list, view our report

Market trend

  • Adoption of NGS in cancer diagnostics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY

  • Segmentation by technology
  • Comparison by technology
  • Conventional testing - Market size and forecast 2017-2022
  • Non-conventional testing - Market size and forecast 2017-2022
  • Market opportunity by technology

PART 08: CUSTOMER LANDSCAPE

PART 09: SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2017-2022
  • Diagnostic laboratories - Market size and forecast 2017-2022
  • Academic and research institutes - Market size and forecast 2017-2022
  • Market opportunity by end-user

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Adoption of NGS in cancer diagnostics
  • Preference for liquid biopsy over traditional biopsy
  • Increase in investment in cancer research

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Danaher
  • F. Hoffmann-La Roche
  • Illumina
  • Thermo Fisher Scientific

PART 15: APPENDIX

  • List of abbreviations
Back to Top